Non - Communicable Diseases and Cancer
Human and animal health is consistently under pressure with various threats including non-communicable diseases, cancers and emerging infectious disease tec. The traditional ways and means of diagnosis and monitoring of treatment progress of many of such diseases being challenged with the complex nature of the diseases. The latest “omics” technologies have given an unpresidential access to molecular pathways of many diseases and conditions where never before seen information can be extracted using minimal or non-invasive sampling methods. Moreover, the research int extracellular vesicles have create a novel platform to understand the earliest communications in the animal and human body which enable to capture some of the new pathways and molecules involved in early pathophysiology of disease inception specially for non-communicable diseases (e.g diabetes and insulin) resistance or cancer (e.g. bone tumours). Moreover, due to the limitation of using human subjects to study these conditions, use of animal models is the only option available. However, not all the animal models will produce data that could be extrapolated to human conditions. Thus, COMBIVET ERA chair is committed to use better comparative medicine approaches to understand selected non-communicable diseases and cancer encompassing EVs as a mode of early detection and prognostic use.
